Cue Biopharma (CUE)
(Delayed Data from NSDQ)
$0.72 USD
+0.02 (3.00%)
Updated Aug 29, 2024 04:00 PM ET
After-Market: $0.72 0.00 (-0.14%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth A Momentum D VGM
Earnings News For CUE
-
Cue Biopharma Reports Second Quarter 2024 Financial Results and Recent Business Highlights
-
Cue Biopharma, Inc. (CUE) Reports Q2 Loss, Tops Revenue Estimates
-
Cue Biopharma Reports First Quarter 2024 Financial Results and Recent Business Highlights
-
Cue Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Updated Business Highlights
-
Cue Biopharma Reports Third Quarter 2023 Financial Results and Recent Business Highlights
-
Cue Biopharma Reports Second Quarter 2023 Financial Results and Recent Business Highlights
-
Cue Biopharma, Inc. (CUE) Reports Q1 Loss, Misses Revenue Estimates
-
Cue Biopharma Reports First Quarter 2023 Financial Results and Recent Business Highlights
-
Cue Biopharma Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Business Highlights
-
Cue Biopharma Reports Third Quarter 2022 Financial Results
-
Analysts Estimate Cue Biopharma, Inc. (CUE) to Report a Decline in Earnings: What to Look Out for
-
Earnings Preview: Cue Biopharma, Inc. (CUE) Q2 Earnings Expected to Decline
-
Cue Biopharma, Inc. (CUE) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
-
Cue Biopharma, Inc. (CUE) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
-
Cue Biopharma, Inc. (CUE) Expected to Beat Earnings Estimates: Should You Buy?